Main menu button

News

Equity Research Ecoclime, Q3 2023: The Evertherm growth journey continues
09 Nov 2023
Equity Research Ecoclime, Q3 2023: The Evertherm growth journey continues
Equity Research
Equity research Observit, Q3 2023: New licenses to boost software revenues
09 Nov 2023
Equity research Observit, Q3 2023: New licenses to boost software revenues
Equity Research Observit
Equity Research ALM Equity, Q3 2023: Worse-than-expected results, but cash of SEK 1.1 billion
09 Nov 2023
Equity Research ALM Equity, Q3 2023: Worse-than-expected results, but cash of SEK 1.1 billion
Equity Research ALM Equity
Equity research Abera: Collaboration validates platform and provides financing
08 Nov 2023
Equity research Abera: Collaboration validates platform and provides financing
Equity Research Abera Bioscience
Carlsquare weekly market letter: Yellen triggers a great rebound. A new politics in the coming?
08 Nov 2023
Carlsquare weekly market letter: Yellen triggers a great rebound. A new politics in the coming?
Equity Research Carlsquare
Equity research Observit, Q3 2023: Good development in profitability and cash flow
07 Nov 2023
Equity research Observit, Q3 2023: Good development in profitability and cash flow
Equity Research Observit
Equity Research HANZA: First impression Q3, 2023
07 Nov 2023
Equity Research HANZA: First impression Q3, 2023
Equity Research Hanza
Equity Research InCoax, Q3 2023: Access and home network customer interest
06 Nov 2023
Equity Research InCoax, Q3 2023: Access and home network customer interest
Equity Research InCoax
First Impression InCoax, Q3 2023: Sales much higher than expected
03 Nov 2023
First Impression InCoax, Q3 2023: Sales much higher than expected
Equity Research InCoax
Carlsquare weekly market letter: Will the pain trade continue?
01 Nov 2023
Carlsquare weekly market letter: Will the pain trade continue?
Equity Research Carlsquare
Analyzing Nordic Biotech: News, Performance, Valuations, Big Pharma, Deals and Future Catalysts
31 Oct 2023
Analyzing Nordic Biotech: News, Performance, Valuations, Big Pharma, Deals and Future Catalysts
Equity Research Kancera
Equity Research H&D Wireless, Q3 2023: More revenue from Labs should help boost earnings
30 Oct 2023
Equity Research H&D Wireless, Q3 2023: More revenue from Labs should help boost earnings
Equity Research
First Impression H&D Wireless, Q3 2023: To be cash flow positive with current cash
27 Oct 2023
First Impression H&D Wireless, Q3 2023: To be cash flow positive with current cash
Equity Research
Carlsquare weekly market letter: Pain trade coming up?
25 Oct 2023
Carlsquare weekly market letter: Pain trade coming up?
Equity Research Carlsquare
Preview SBB i Norden, Q3 2023: Less distressed following Educo transaction
24 Oct 2023
Preview SBB i Norden, Q3 2023: Less distressed following Educo transaction
Equity Research SBB i Norden
Equity research Arctic Minerals: Looking for new partnerships
20 Oct 2023
Equity research Arctic Minerals: Looking for new partnerships
Equity Research Arctic Minerals
Equity research, HANZA: Preview Q3, 2023
19 Oct 2023
Equity research, HANZA: Preview Q3, 2023
Equity Research Hanza
Carlsquare weekly market letter: Something has to give
18 Oct 2023
Carlsquare weekly market letter: Something has to give
Equity Research Carlsquare
Carlsquare weekly market letter: Turnaround could last until year-end
11 Oct 2023
Carlsquare weekly market letter: Turnaround could last until year-end
Equity Research Carlsquare
Equity Research Zazz Energy: Further delays, capital raise in the cards
06 Oct 2023
Equity Research Zazz Energy: Further delays, capital raise in the cards
Equity Research